IRESSA
As listed in the register: IRESSA
250 mg · tablet
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Gefitinib
- Made by
- Astrazeneca Canada Inc
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United States5 matching products
European UnionNo exact match for this strength and form
Spain10 matching products
- GEFITINIB ACCORD 250 mg · comprimido recubierto con película
- GEFITINIB ARISTO 250 mg · comprimido recubierto con película
- GEFITINIB CIPLA 250 mg · comprimido recubierto con película
- GEFITINIB EUGIA 250 mg · comprimido recubierto con película
- GEFITINIB GENTHON 250 mg · comprimido recubierto con película
- GEFITINIB MYLAN 250 mg · comprimido recubierto con película
- GEFITINIB QILU 250 mg · comprimido recubierto con película
- GEFITINIB SALA 250 mg · comprimido recubierto con película
Netherlands9 matching products
- Gefitinib Synthon 250 mg 250 mg · filmomhulde tablet2 makers
- Gefitinib Eugia 250 mg filmomhulde tabletten 250 mg · filmomhulde tablet
- Gefitinib Genthon 250 mg 250 mg · filmomhulde tablet
- Gefitinib Glenmark 250 mg filmomhulde tabletten 250 mg · filmomhulde tablet
- Gefitinib Sandoz 250 mg 250 mg · filmomhulde tablet
- Gefitinib Stada 250 mg 250 mg · filmomhulde tablet
- Gefitinib Teva 250 mg 250 mg · filmomhulde tablet
- Iressa 250 mg · filmomhulde tablet
SwitzerlandNo exact match for this strength and form
Details
| Made by | Astrazeneca Canada Inc |
|---|---|
| Active substance | Gefitinib |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 250 mg |
| Form | tablet |
| Classification | L01EB01 · Cancer treatments and immune-system medicines |
| Route | oral |
| Dispensing (as stated by the register) | PRESCRIPTION |
| Status | Marketed |
| Marketed | Yes, according to the register |
| DIN | 02248676 |
| DPD drug code | 73040 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.